Cell line translation image courtesy of the Consortium
"Will Genomics Revolutionize Cancer Therapy?" Find out when the Fred Hutchinson/University of Washington Cancer Consortium present this daylong symposium Wednesday, May 23, 9 a.m.- 4:45 p.m. in Pelton Auditorium, Weintraub Building, B1-065.
Symposium speakers and presentations include:
- Dr. Henry Lynch, Creighton University School of Medicine
"Hereditary Cancer Models in the Quest for Genomics Revolutionizing Cancer Therapy"
- Dr. Peter Nelson, Hutchinson Center
"Exploiting Cancer Diversity to Deliver Appropriate Therapy"
- Dr. David Solit, Memorial Sloan-Kettering Cancer Center
"Genetic Determinants of mTOR Dependence"
- Dr. Samuel Aparicio, University of British Columbia, BC Cancer Agency Research Centre
"Clonal and Mutational Spectrum of Breast Cancers"
- Dr. Mary-Claire King, University of Washington
"Next Generation Sequencing of Inherited Breast and Ovarian Cancer: Fulfilling a Promise of Personalized Genomic Medicine"
- Dr. Funmi Olopade, The University of Chicago
"Making the Case for Data Integration on the Way to Precision Medicine"
- Dr. Timothy Ley, Washington University in St. Louis
"The AML Genome"
- Dr. Jerald Radich, Hutchinson Center
"The Genetics of Response and Progression in Myeloid Leukemia"
- Dr. Marshall Horwitz, UW
(Leading symposium introduction)
- Dr. Stephen Friend, president, co-founder and director of Sage Bionetworks
(Leading panel discussion)
The symposium is free, but space is limited and registration, which includes lunch, is required. Register and access the agenda here.
Parking is extremely limited at the Hutchinson Center campus. You are highly encouraged to take alternate modes of transportation.
For additional information, please contact Danielle Parsons at firstname.lastname@example.org.
This event is sponsored by the Cancer Consortium, a research collaboration between the Center, UW, Seattle Children's and Seattle Cancer Care Alliance that brings together more than 400 faculty with research interests in basic, clinical and public health sciences related to cancer.